TrialOpen forum infectious diseases2026

Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.

Camille N Kotton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.